Anti-AKR1B15 antibodies are used in the immunodetection of the protein aldo-keto reductase family 1 member B15. In humans, the canonical protein has a reported length of 316 amino acid residues and a mass of 36.5 kDa. Its subcellular localization is in the mitochondria and cytoplasm. Up to 2 different isoforms have been reported for this protein. It is widely expressed across many tissue types. A member of the Aldo/keto reductase protein family, AKR1B15 is known to catalyze the NADPH-dependent reduction of a variety of carbonyl substrates, like aromatic aldehydes, alkenals, ketones and alpha-dicarbonyl compounds. Synonyms for this target antigen include farnesol dehydrogenase, putative aldo-keto reductase family 1 member B15, testosterone 17beta-dehydrogenase, and estradiol 17-beta-dehydrogenase AKR1B15. AKR1B15 gene orthologs have been reported in the mouse, rat and chimpanzee species. Indicated applications for AKR1B15 antibodies listed below include Western Blot.